isovitexin

12/01/2021 - "Isovitexin ameliorates joint inflammation in acute GA via the TLR4/MyD88/NF-κB pathway. "
05/01/2005 - "Our results suggest that suppression of ROS-mediated COX-2 expression by isovitexin is beneficial in reducing inflammation and carcinogenesis."
09/01/2023 - "Isovitexin prevents DSS-induced colitis through inhibiting inflammation and preserving intestinal barrier integrity through activating AhR."
12/01/2021 - "Isovitexin alleviates acute gouty arthritis in rats by inhibiting inflammation via the TLR4/MyD88/NF-κB pathway."
02/01/2023 - "The effect of isovitexin on lipopolysaccharide-induced renal injury and inflammation by induction of protective autophagy."

01/01/2021 - "Importantly, isovitexin notably suppressed tumor growth in nude mice bearing LCSLCs by downregulation of MnSOD expression. "
06/17/2019 - "Isovitexin exhibits antitumor activities in various cancers. "
01/01/2023 - "Isovitexin Suppresses Cancer Stemness Property and Induces Apoptosis of Osteosarcoma Cells by Disruption of the DNMT1/miR-34a/Bcl-2 Axis [Retraction]."
12/01/2021 - "Isovitexin attenuates tumor growth in human colon cancer cells through the modulation of apoptosis and epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway."
01/01/2019 - "Isovitexin Suppresses Cancer Stemness Property And Induces Apoptosis Of Osteosarcoma Cells By Disruption Of The DNMT1/miR-34a/Bcl-2 Axis."

09/01/2023 - "Isovitexin prevents DSS-induced colitis through inhibiting inflammation and preserving intestinal barrier integrity through activating AhR."
09/01/2023 - "In the present study, we aimed to explore the protective effects of isovitexin on colitis using the dextran sodium sulfate (DSS)-induced model. "

05/01/2005 - "Our results suggest that suppression of ROS-mediated COX-2 expression by isovitexin is beneficial in reducing inflammation and carcinogenesis."

01/01/2021 - "Our study was aimed at investigating whether isovitexin inhibits lung cancer stem-like cells (LCSLCs) through MnSOD signaling blockage and glycolysis suppression. "
01/01/2021 - "Isovitexin Suppresses Stemness of Lung Cancer Stem-Like Cells through Blockage of MnSOD/CaMKII/AMPK Signaling and Glycolysis Inhibition."
05/01/2021 - "Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice."